{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:11:45Z","timestamp":1790626305560,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejphar.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T18:48:14Z","timestamp":1520621294000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia"],"prefix":"10.1016","volume":"827","author":[{"given":"Tetsuo","family":"Kiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Funatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.03.011_bib1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jad.2013.08.032","article-title":"Possible involvement of oxido-nitrosative stress induced neuro-inflammatory cascade and monoaminergic pathway: underpinning the correlation between nociceptive and depressive behaviour in a rodent model","volume":"151","author":"Arora","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2018.03.011_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/DHPS.S95535","article-title":"Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia","volume":"8","author":"Bhusal","year":"2016","journal-title":"Drug Healthc. Patient Saf."},{"key":"10.1016\/j.ejphar.2018.03.011_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.physbeh.2015.07.033","article-title":"Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats","volume":"151","author":"Blasco-Serra","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2018.03.011_bib4","first-page":"585419","article-title":"Neurobiology underlying fibromyalgia symptoms","volume":"2012","author":"Ceko","year":"2012","journal-title":"Pain Res. Treat."},{"key":"10.1016\/j.ejphar.2018.03.011_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2017.04.017","article-title":"Spinal dopaminergic involvement in the antihyperalgesic effect of antidepressants in a rat model of neuropathic pain","volume":"649","author":"Chen","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2018.03.011_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/ar4402","article-title":"Animal models of fibromyalgia","volume":"15","author":"DeSantana","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2018.03.011_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.33339","article-title":"Reduced insular gamma-aminobutyric acid in fibromyalgia","volume":"64","author":"Foerster","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2018.03.011_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/ALN.0b013e31818dac9c","article-title":"Gabapentin acts within the locus coeruleus to alleviate neuropathic pain","volume":"109","author":"Hayashida","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2018.03.011_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1213\/ANE.0000000000002352","article-title":"Repeated administration of amitriptyline in neuropathic pain: modulation of the noradrenergic descending inhibitory system","volume":"125","author":"Hiroki","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2018.03.011_bib10","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.21191","article-title":"A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications","volume":"52","author":"Holman","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2018.03.011_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.mayocp.2013.09.021","article-title":"Relation of age with symptom severity and quality of life in patients with fibromyalgia","volume":"89","author":"Jiao","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2018.03.011_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/jpet.104.075960","article-title":"Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents","volume":"312","author":"Jones","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.03.011_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0079-6123(08)63824-8","article-title":"Descending noradrenergic influences on pain","volume":"88","author":"Jones","year":"1991","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2018.03.011_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","article-title":"Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition","volume":"114","author":"Julien","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.03.011_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3565(25)24303-8","article-title":"Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex","volume":"272","author":"Kihara","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.03.011_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","article-title":"Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice","volume":"86","author":"Klein","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.03.011_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3959(00)00284-0","article-title":"Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways","volume":"87","author":"Larson","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.03.011_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-016-3468-5","article-title":"Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials","volume":"36","author":"Lee","year":"2016","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ejphar.2018.03.011_bib19","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/art.20486","article-title":"Balanced treatments for fibromyalgia","volume":"50","author":"Littlejohn","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2018.03.011_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2018.03.011_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s003930050229","article-title":"Descending antinociception and fibromyalgia","volume":"57","author":"Mense","year":"1998","journal-title":"Z. Rheumatol."},{"key":"10.1016\/j.ejphar.2018.03.011_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Moron","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.03.011_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/jpet.113.208686","article-title":"AS1069562, the (+)-isomer of indeloxazine, exerts analgesic effects in a rat model of neuropathic pain with unique characteristics in spinal monoamine turnover","volume":"348","author":"Murai","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.03.011_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neuroscience.2014.12.065","article-title":"Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats","volume":"289","author":"Murai","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2018.03.011_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia","volume":"146","author":"Nagakura","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.03.011_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2013.04.007","article-title":"Systemic administration of 5-HT(2C) receptor agonists attenuates muscular hyperalgesia in reserpine-induced myalgia model","volume":"108","author":"Ogino","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.03.011_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2006.08.001","article-title":"Noradrenergic pain modulation","volume":"80","author":"Pertovaara","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2018.03.011_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/AJP.0000000000000474","article-title":"Measuring glutamate levels in the brains of fibromyalgia patients and a potential role for glutamate in the pathophysiology of fibromyalgia symptoms: a systematic review","volume":"33","author":"Pyke","year":"2017","journal-title":"Clin. J. Pain."},{"key":"10.1016\/j.ejphar.2018.03.011_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0028-3908(84)90097-2","article-title":"5-Hydroxytryptamine and antinociception","volume":"23","author":"Roberts","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.03.011_bib30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","article-title":"Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis","volume":"35","author":"Russell","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2018.03.011_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(72)90260-0","article-title":"Effects of reserpine and monoamine oxidase inhibition on the levels of amino acids in sensory ganglia, sympathetic ganglia and spinal cord","volume":"47","author":"Santini","year":"1972","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2018.03.011_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2014.03.046","article-title":"The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration","volume":"568","author":"Sun","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2018.03.011_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.j.pain.0000460334.49525.5e","article-title":"Peripheral and spinal mechanisms of nociception in a rat reserpine-induced pain model","volume":"156","author":"Taguchi","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.03.011_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2016.01.025","article-title":"Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors","volume":"615","author":"Tamano","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2018.03.011_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2010.09.034","article-title":"In vivo patch-clamp analysis of dopaminergic antinociceptive actions on substantia gelatinosa neurons in the spinal cord","volume":"152","author":"Taniguchi","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.03.011_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jpain.2006.11.007","article-title":"Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats","volume":"8","author":"Yokoyama","year":"2007","journal-title":"J. Pain."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918301468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918301468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:19:41Z","timestamp":1751476781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918301468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":36,"alternative-id":["S0014299918301468"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.03.011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}